The BH3 domain of BAD fused to the Antennapedia peptide induces apoptosis via its alpha helical structure and independent of Bcl-2
- 1 July 2001
- journal article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 8 (7) , 725-733
- https://doi.org/10.1038/sj.cdd.4400870
Abstract
Cell death and differentiation is a monthly research journal focused on the exciting field of programmed cell death and apoptosis. It provides a single accessible source of information for both scientists and clinicians, keeping them up-to-date with advances in the field. It encompasses programmed cell death, cell death induced by toxic agents, differentiation and the interrelation of these with cell proliferation.Keywords
This publication has 30 references indexed in Scilit:
- Anti-cancer activity of targeted pro-apoptotic peptidesNature Medicine, 1999
- Bad Is a BH3 Domain-Containing Protein That Forms an Inactivating Dimer with Bcl-XLMolecular and Cellular Biology, 1997
- BH3 Domain of BAD Is Required for Heterodimerization with BCL-XL and Pro-apoptotic ActivityJournal of Biological Chemistry, 1997
- REGULATION OF CLINICAL CHEMORESISTANCE BY bcl‐2 AND BAX ONCOPROTEINS IN B‐CELL CHRONIC LYMPHOCYTIC LEUKAEMIABritish Journal of Haematology, 1996
- Insertion and Orientation of a Synthetic Peptide Representing the C-Terminus of the A1 Domain of Shiga Toxin into Phospholipid MembranesBiochemistry, 1996
- Response to interferon therapy in patients with multiple myeloma correlates with expression of the Bcl-2 oncoproteinInternational Journal of Cancer, 1995
- Reversal of Chemoresistance of Lymphoma Cells by Antisense-Mediated Reduction ofbcl-2 Gene ExpressionAntisense Research and Development, 1994
- Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell lineBlood, 1993
- Design of model amphipathic peptides having potent antimicrobial activitiesBiochemistry, 1992
- All‐D‐magainin: chirality, antimicrobial activity and proteolytic resistanceFEBS Letters, 1990